PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1518516
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1518516
Hydroxyzine Market, By Dosage Form, Route of Administration, Indication, Distribution Channel - Global Forecast
Hydroxyzine market size is expected to register 5.4% CAGR between 2024 and 2032 driven by the increasing prevalence of anxiety disorders, allergies, and related conditions. According to the U.S. Census Bureau Household Pulse Survey, approximately one-third of adults (32.3%) experienced symptoms of anxiety and depression in 2023. The expanding geriatric population, which is more susceptible to chronic health issues is making way for antihistamine treatment. This has led to the higher rate of prescriptions for hydroxyzine as part of comprehensive treatment plans.
Technological advancements in pharmaceutical formulations and delivery methods will also influence the market growth. Enhanced drug delivery systems, such as sustained-release formulations are improving patient compliance and therapeutic outcomes, further encouraging wider adoption. The availability of hydroxyzine in various forms, including tablets, capsules, and suspensions is helping to cater to diverse patient needs and preferences. The ongoing R&D activities aimed at discovering new therapeutic uses will also propel the product demand.
Hydroxyzine industry is segmented into dosage form, route of administration, indication, distribution channel, and region.
Based on dosage form, the market size from the capsules segment is slated to witness significant CAGR during 2024-2032 due to its advantages of ease of administration, better patient compliance, and improved bioavailability. Capsules are often preferred by patients and healthcare providers as they are easier to swallow compared to tablets, particularly for those with difficulty swallowing or experiencing nausea.
Hydroxyzine market from the online pharmacies distribution channel segment is predicted to record decent growth rate through 2032, owing to the greater accessibility and convenience to patients seeking medications. The rise of e-commerce in the pharmaceutical sector allows patients to purchase hydroxyzine easily from the comfort of their homes while eliminating the need for physical visits to traditional brick-and-mortar pharmacies. Online pharmacies also offer competitive pricing and discounts, making hydroxyzine more affordable and attractive to a broader audience.
Asia Pacific hydroxyzine industry is poised to depict lucrative growth during 2024-2032, attributed to the increasing prevalence of allergic conditions and mental health disorders due to rapid urbanization and lifestyle changes. The growing awareness about mental health issues and the reduction of social stigma associated with seeking treatment have led to the higher diagnosis and treatment rate for anxiety disorders, subsequently adding to the regional product penetration.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market scope & definitions
- 1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
- 1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
- 1.4 Forecast model
- 1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources
Chapter 2 Executive Summary
- 2.1 Industry 360 degree synopsis
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Increasing allergic reaction among the target population
- 3.2.1.2 Increasing research and development investments
- 3.2.1.3 Technological advancements in drug delivery systems
- 3.2.1.4 Expanding applications beyond allergic reactions
- 3.2.2 Industry pitfalls & challenges
- 3.2.2.1 Side effects associated with the medication
- 3.2.2.2 Stringent regulatory scenario
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Technological landscape
- 3.5 Regulatory landscape
- 3.6 Porter's analysis
- 3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.2 Company market share analysis
- 4.3 Competitive positioning matrix
- 4.4 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Dosage Form, 2021 - 2032 ($ Mn)
- 5.1 Key trends
- 5.2 Tablets
- 5.3 Capsules
- 5.4 Injections
- 5.5 Syrups
Chapter 6 Market Estimates and Forecast, By Route of Administration, 2021 - 2032 ($ Mn)
- 6.1 Key trends
- 6.2 Oral
- 6.3 Intramuscular
Chapter 7 Market Estimates and Forecast, By Indication, 2021 - 2032 ($ Mn)
- 7.1 Key trends
- 7.2 Histamine-mediated pruritus
- 7.3 Urticaria
- 7.4 Atopic contact dermatitis
Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)
- 8.1 Key trends
- 8.2 Hospital pharmacies
- 8.3 Retail pharmacies
- 8.4 Online pharmacies
Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)
- 9.1 Key trends
- 9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
- 9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
- 9.3.7 Rest of Europe
- 9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
- 9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
- 9.6 Middle East and Africa
- 9.6.1 Saudi Arabia
- 9.6.2 South Africa
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
- 10.1 Alliance Pharma Plc
- 10.2 Amneal Pharmaceuticals, Inc.
- 10.3 Aurobindo Pharma Limited
- 10.4 Glenmark Pharmaceuticals Ltd.
- 10.5 MYLAN N.V.
- 10.6 Novartis AG
- 10.7 Pfizer Inc.
- 10.8 Piramal Enterprises Limited
- 10.9 Sun Pharmaceutical Industries Limited
- 10.10 Teva Pharmaceutical Industries Limited
